Prognostic value of the hematocrit in patients with severe COPD receiving long-term oxygen therapy - PubMed (original) (raw)
Prognostic value of the hematocrit in patients with severe COPD receiving long-term oxygen therapy
Arnaud Chambellan et al. Chest. 2005 Sep.
Erratum in
- Chest. 2006 Mar;129(3):831
Abstract
Background: Although traditionally associated with polycythemia, COPD has a systemic inflammatory component that could interfere with erythropoiesis. This study describes the distribution and prognostic value of the hematocrit in patients with severe COPD receiving long-term oxygen therapy (LTOT).
Methods: A total of 2,524 patients with COPD, FEV1/vital capacity (VC) < 70%, FEV1 < 80% of predicted, and Pa(O2) < 7.3 kPa in whom a hematocrit was available at entry was identified between 1980 and 1999 in the French Association Nationale pour le Traitement à Domicile de l'Insuffisance Respiratoire chronic respiratory insufficiency and home-care database (male/female ratio, 5/1; mean +/- SD age, 68 +/- 10 years for men, and 70 +/- 10 years for women). Correlations between hematocrit, demographic data, and pulmonary function data were examined. A multivariate Cox proportional hazard regression was performed to identify prognostic factors.
Results: Mean hematocrit was 45.9 +/- 7.0% in men and 43.9 +/- 6.0% in women (< 39% in 12.6% of men, and < 36% in 8.2% of women) according to the World Health Organization definition of anemia. Hematocrit was negatively correlated with age (r = - 0.245) and FEV1/VC (r = - 0.068) and was positively correlated with Pa(CO2) (r = 0.161) and body mass index (r = 0.127). Multivariate analysis found hematocrit to be an independent predictor of survival, hospital admission rate, and cumulative duration of hospitalization. The 3-year survival was 24% (95% confidence interval, 16 to 33%) when the hematocrit was < 35%, and 70% (63 to 76%) when the hematocrit was > or = 55%.
Conclusions: A low hematocrit is not uncommon in LTOT/COPD patients. Hematocrit is negatively associated with mortality and morbidity. Whether the association is causative or not and whether or not corrective measures are warranted remain to be determined.
Similar articles
- Prognostic value of nutritional depletion in patients with COPD treated by long-term oxygen therapy: data from the ANTADIR observatory.
Chailleux E, Laaban JP, Veale D. Chailleux E, et al. Chest. 2003 May;123(5):1460-6. doi: 10.1378/chest.123.5.1460. Chest. 2003. PMID: 12740261 - Potentially modifiable predictors of mortality in patients treated with long-term oxygen therapy.
Lima DF, Dela Coleta K, Tanni SE, Silveira LV, Godoy I, Godoy I. Lima DF, et al. Respir Med. 2011 Mar;105(3):470-6. doi: 10.1016/j.rmed.2010.08.012. Epub 2010 Sep 16. Respir Med. 2011. PMID: 20846839 - Predictors of survival in patients receiving domiciliary oxygen therapy or mechanical ventilation. A 10-year analysis of ANTADIR Observatory.
Chailleux E, Fauroux B, Binet F, Dautzenberg B, Polu JM. Chailleux E, et al. Chest. 1996 Mar;109(3):741-9. doi: 10.1378/chest.109.3.741. Chest. 1996. PMID: 8617085 - The potential impact of anaemia of chronic disease in COPD.
Similowski T, Agustí A, MacNee W, Schönhofer B. Similowski T, et al. Eur Respir J. 2006 Feb;27(2):390-6. doi: 10.1183/09031936.06.00143704. Eur Respir J. 2006. PMID: 16452598 Review. - The paradigm shift from polycythemia to anemia in COPD: the critical role of the renin-angiotensin system inhibitors.
Vlahakos V, Marathias K, Lionaki S, Loukides S, Zakynthinos S, Vlahakos D. Vlahakos V, et al. Expert Rev Respir Med. 2022 Apr;16(4):391-398. doi: 10.1080/17476348.2022.2045958. Epub 2022 Mar 1. Expert Rev Respir Med. 2022. PMID: 35212601 Review.
Cited by
- A Diagnostic Nomogram for Predicting Hypercapnic Respiratory Failure in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
Zhou Z, Wang Y, Wang Y, Yang B, Xu C, Wang S, Yang W. Zhou Z, et al. Int J Chron Obstruct Pulmon Dis. 2024 May 18;19:1079-1091. doi: 10.2147/COPD.S454558. eCollection 2024. Int J Chron Obstruct Pulmon Dis. 2024. PMID: 38783895 Free PMC article. - Prevalence and clinical impact of anemia in patients diagnosed with chronic obstructive pulmonary disease: A cross-sectional study.
Rimal S, Das SK, Basnet A, Rauniyar TP, Pandey KR, Kuikel S. Rimal S, et al. Health Sci Rep. 2023 Jun 27;6(6):e1371. doi: 10.1002/hsr2.1371. eCollection 2023 Jun. Health Sci Rep. 2023. PMID: 37388270 Free PMC article. - Polycythemia among Patients with Chronic Obstructive Pulmonary Disease Admitted to the Department of Medicine in a Tertiary Care Center: A Descriptive Cross-sectional Study.
Thapa KB, Paudel A, Dhital S, Shrestha A, Ojha L, Shrestha A. Thapa KB, et al. JNMA J Nepal Med Assoc. 2023 Apr 1;61(260):343-346. doi: 10.31729/jnma.8125. JNMA J Nepal Med Assoc. 2023. PMID: 37208878 Free PMC article. - Chronic Obstructive Pulmonary Disease and Its Effect on Red Blood Cell Indices.
Tariq S, Ismail D, Thapa M, Goriparthi L, Pradeep R, Khalid K, Cooper AC, Jean-Charles G. Tariq S, et al. Cureus. 2023 Mar 13;15(3):e36100. doi: 10.7759/cureus.36100. eCollection 2023 Mar. Cureus. 2023. PMID: 37065412 Free PMC article. Review. - Anemia as a Significant Predictor of Adverse Outcomes in Hospitalized Patients With Acute Exacerbations of Chronic Obstructive Pulmonary Disease: Analysis of National (Nationwide) Inpatient Sample Database.
Sonani H, Dhaduk K, Dankhara N, Viroliya K, Desai CH, Sonani AA, Patel AS, Palabindala V, Goti AM, Desai J. Sonani H, et al. Cureus. 2023 Jan 29;15(1):e34343. doi: 10.7759/cureus.34343. eCollection 2023 Jan. Cureus. 2023. PMID: 36865975 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical